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1  | INTRODUC TION
Acute kidney injury (AKI) is a frequently occurring complication 
of critical illness, with severe impact on morbidity and mortality. 
Incidences up to 60% have been reported, depending on defini‐
tions and populations studied.1,2 Many studies focus on advanced 
measures, such as biomarkers 3 or imaging 4 for predicting AKI. 
These techniques are frequently time‐consuming, costly, and are 
not available on a global scale.5 In contrast, variables obtained by 
clinical examination are readily available without limitations by set‐
tings or costs. Clinical examination signs and symptoms may reflect 
the underlying disease state and could therefore potentially be used 
to identify patients at risk for AKI. Clinical examination is always 
the first diagnostic test in each new patient or each new diagnostic 
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Background: Acute Kidney Injury (AKI) in critically ill patients is associated with a 
markedly increased morbidity and mortality. The aim of this study was to establish 
the predictive value of clinical examination for AKI in critically ill patients.
Methods: This was a sub‐study of the SICS‐I, a prospective observational cohort 
study of critically ill patients acutely admitted to the Intensive Care Unit (ICU). Clinical 
examination was performed within 24 hours of ICU admission. The occurrence of AKI 
was determined at day two and three after admission according to the KDIGO defini‐
tion including serum creatinine and urine output. Multivariable regression modeling 
was used to assess the value of clinical examination for predicting AKI, adjusted for 
age, comorbidities and the use of vasopressors.
Results: A total of 1003 of 1075 SICS‐I patients (93%) were included in this sub‐
study. 414 of 1003 patients (41%) fulfilled the criteria for AKI. Increased heart rate 
(OR 1.12 per 10 beats per minute increase, 98.5% CI 1.04‐1.22), subjectively cold 
extremities (OR 1.52, 98.5% CI 1.07‐2.16) and a prolonged capillary refill time on the 
sternum (OR 1.89, 98.5% CI 1.01‐3.55) were associated with AKI. This multivariable 
analysis yielded an area under the receiver‐operating curve (AUROC) of 0.70 (98.5% 
CI 0.66‐0.74). The model performed better when lactate was included (AUROC of 
0.72, 95%CI 0.69‐0.75), P = .04.
Conclusion: Clinical examination findings were able to predict AKI with moderate 
accuracy in a large cohort of critically ill patients. Findings of clinical examination on 
ICU admission may trigger further efforts to help predict developing AKI.
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dilemma. Specifically in the Intensive Care Unit (ICU) clinical exami‐
nation may differentiate between types of shock, eg sepsis or hy‐
povolemia,6 which are in itself associated with AKI through various 
pathophysiological mechanisms including hypoperfusion, immune 
response, and drug toxicity. Early risk stratification may ultimately 
accelerate preventive measures to protect renal function in the criti‐
cally ill.7‐10 The aim of this study was to investigate the predictive 
value of clinical examination findings as readily available measures 
for AKI.
2  | METHODS
This was a sub‐study of the Simple Intensive Care Studies‐I 
(SICS‐I), a single‐centre, prospective observational cohort study 
(NCT02912624).11
Ethics: The local institutional review board approved the study 
(M15.168207).
2.1 | Participants and study size
All patients of 18 years and older who were acutely admitted to the 
ICU, with an expected ICU stay of at least 24 hours, were eligible 
for inclusion in the SICS‐I. Exclusion criteria were discharge within 
24 hours and no informed consent. Patients with known chronic kid‐
ney disease before ICU admission (defined by serum creatinine above 
177 µmol/L following definition of the Dutch National Intensive 
Care Evaluation registry12,13) were excluded from this analysis.
2.2 | Variables
Patient characteristics were registered at admission.14 All patients 
underwent clinical examination within 24 hours after ICU admission 
according to a prespecified protocol. All measurements were con‐
ducted by trained researchers who were not involved in patient care 
and took place as early as possible after ICU admission. Their find‐
ings were not revealed to the patients’ caregivers. All clinical exami‐
nations were standardized and cut‐off values for abnormal clinical 
signs were predefined in the protocol and summarized in E‐Table 1 
(clinicaltrials.gov; NCT02912624). In the SICS‐I, blood pressure data 
were obtained from both invasive arterial continuous measurement 
and non‐invasive oscillometry. The non‐invasive measurements 
were used when available as this method is more generalizable to 
other settings than the ICU.
2.3 | Definitions
AKI and its severity were defined according to the KDIGO defini‐
tion based on serum creatinine, urinary output and RRT (renal re‐
placement therapy) criteria.15 Indications to start RRT were based on 
clinical judgment by the treating physician and included metabolic 
acidosis, hyperkalemia, and anuria or oliguria especially in combina‐
tion with clinical signs of volume overload. AKI, defined as KDIGO 
stage I or higher, was determined on day two and day three after 
ICU admission as the predictive value of clinical examination on day 
one was investigated. The Modification of Diet in Renal Disease 
(MDRD) formula was used for estimation of the ideal serum creati‐
nine for each individual at baseline assuming a creatinine clearance 
of 75 ml/min/1.73m2.16,17 Comorbidity data were defined following 
the Dutch National Intensive Care Evaluation (NICE) registry.12,13 
Capillary refill time (CRT) was the time for skin color to fully return 
after applying firm pressure at the sternum, index finger, and knee 
for 15 seconds and considered prolonged if > 4.5 seconds. The dif‐
ference between central temperature (Tc) measured by a bladder 
thermistor catheter and peripheral temperature (Tp) measured by a 
skin probe was the delta temperature (ΔTc–p) and considered abnor‐
mal if > 7°C. This was measured for both the foot (ΔTc–pf) and the 
big toe (ΔTc–pt).11
2.4 | Statistical analyses
The overall statistical methods were described in the statistical 
analysis plan of SICS‐I (NCT02912624). Continuous variables were 
reported as means and standard deviations (SD) or median and in‐
terquartile ranges (IQR) for normally distributed and skewed vari‐
ables respectively. Categorical data were presented in proportions. 
Associations were calculated as odds ratios (OR) with confidence 
Editorial comment
This study assessed the strength of association for differ‐
ent routine clinical bedside physical findings on ICU admis‐
sion with developing acute kidney injury later on during 
ICU stay, in a secondary analysis of observations in a large 
cohort study. Higher heart rates, colder extremities, and 
prolonged capillary refill were more likely in patients who 
later during their ICU stay developed acute kidney injury.
TA B L E  1   Baseline characteristics of included patients
 N = 1003
Age, years (SD) 62 (15)
Gender, male (%) 623 (62)
BMI, kg/m2 (SD) 26.9 (5.4)
Diabetes mellitus, n (%) 191 (19)
Liver cirrhosis, n (%) 47 (4.7)
Mechanical ventilation at inclusion, n (%) 597 (60)
Use of vasopressors at inclusion, n (%) 499 (50)
Use of RRT during first 3 days, n (%) 50 (5.0)
APACHE IV, score (SD) 74.9 (28.9)
Note: SD, standard deviation, BMI, body mass index, RRT, renal re‐
placement therapy, APACHE IV, acute physiology and chronic health 
evaluation.
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intervals (CI). Student's T‐test, Mann‐Whitney U test or the Chi‐
square tests were used as appropriate. No data were imputed for 
this analysis. Associations between clinical examination and AKI, 
and comorbidities and AKI were first explored by univariate analysis. 
We used univariate associations with P < .1 for entrance of a vari‐
able into the multivariable model, which was decided a priori to be 
adjusted for age and vasopressor use regardless of their univariate 
association. The final model was based on logistic regression analysis 
to identify variables which were independently associated with AKI. 
Discrimination of the final model was evaluated with receiver op‐
erating characteristic (ROC)‐curves. Calibration of the multivariable 
model was checked with the Hosmer‐Lemeshow (H‐L) Goodness of 
Fit (GoF) test and by plotting observed AKI proportions against pre‐
dicted risks of 10 equally sized groups. Analyses were performed 
using Stata version 15 (StataCorp, College Station, TX, USA).
2.5 | Sensitivity analysis
Two sensitivity analyses were performed. The first sensitivity 
analysis included lactate as variable in the model since lactate 
may be readily available as point of care assessment in some 
ICU’s.18 We assessed whether lactate as a potentially readily 
available variable would improve the model. We recorded the 
serum lactate closest to clinical examination. Second, since all 
variables included in the final multivariable model reflect symp‐
toms of circulatory shock, we also tested whether the presence 
of shock only performed similar compared to the primary model. 
This model included age, comorbidities, and the need for vaso‐
pressors (as proxy for shock).
2.6 | Statistical significance
The SICS‐I was designed to address multiple hypotheses on six dif‐
ferent outcomes and, therefore, the acute kidney injury outcome 
was adjusted for multiple hypothesis testing.14 We refer to our SAP 
for more details, but in short, a P‐value of 0.015 indicated statisti‐
cal significance and p‐values between 0.015 and 0.05 indicated sug‐
gestive significance with an increased family‐wise error rate.19,20 For 
our sensitivity analyses, a P‐value below 0.05 indicated statistical 
significance due to the hypothesis‐generating purpose. Accordingly, 
primary analyses are presented with 98.5% CIs and sensitivity analy‐
ses with 95% CIs.
3  | RESULTS
Between 27 March 2015 and 22 July 22 2017, 1075 patients were 
included in the SICS‐I. Of these, 72 (7%) suffered (known) chronic 
kidney disease before admission and were, therefore, excluded from 
this analysis. Table 1 presents the baseline characteristics of the pa‐
tients included in the cohort. The observed clinical signs are shown 
in Table 2. The median time from ICU admission to inclusion was 
15 hours (IQR 8‐20 h).
From the 1003 included patients, 414 patients (41%) fulfilled the 
criteria for any stage of AKI on day two or three after ICU admis‐
sion. The severity of AKI was stage 1, stage 2 and stage 3 in 148 
(15%), 122 (12%), and 144 (14%) patients respectively (Figure 1). 
In total, 153 patients had AKI based on creatinine, 146 patients 
based on urine output and 115 patients based on both or the use 
of RRT. Heart rate, per 10 beats per minute for convenient clin‐
ical implementation, appeared to have a linear relationship with 
AKI (E‐Figure 1). Low blood pressure, prolonged CRT, abnormal 
ΔTc–p, and subjectively cold temperature were all associated with 
AKI in univariate analysis (E‐Table 2). Collinearity was observed 
between the systolic‐, diastolic‐ and mean arterial blood pressure 
variables, between ΔTc–p on the dorsum of the foot and the big 
toe measurements and the CRT measured on the finger, sternum, 
and knee. Only the variables with the strongest univariable associ‐
ation from the variables that showed collinearity were included in 
the final analyses. The comorbidities cardiovascular insufficiency, 
TA B L E  2   Observed clinical signs
No.  N = 1003
Central circulation
1 Respiratory rate, >22 pm 729 (72.7%)
2 Heart rate,> 100 bpm 290 (28.9%)
3 Atrial fibrillation, present 73 (7.3%)
4 Systolic blood pressure, 
<90 mmHg
98 (9.8%)
5 Diastolic blood pressure, 
<45 mmHg
80 (8.0%)
6 Mean arterial pressure, 
<65 mmHg
150 (15.0%)
7 Cardiac murmurs 84 (9.3%)
8 Crepitations 134 (13.5%)
Organ perfusion
9 Consciousness  
 Alert 736 (73.4%)
 Reacting to voice 161 (16.1%)
 Reacting to pain 38 (3.8%)
 Unresponsive 68 (6.8%)
10 High ΔTc‐p, foot 543 (54.1%)
11 High ΔTc‐p, big toe 690 (68.8%)
12 Subjectively cold 619 (62.1%)
13 Prolonged CRT sternum 79 (7.9%)
14 Prolonged CRT finger 192 (19.1%)
15 Prolonged CRT knee 275 (27.4%)
16 Skin mottling score  
 Mild (0‐1) 683 (68.1%)
 Moderate (2‐3) 290 (28.9%)
 Severe (4‐5) 30 (3.0%)
Note: PM, per minute, BPM, beats per minute, ΔTc‐p, Delta temperature 
central – peripheral, CRT, capillary refill time. ΔTc‐p was considered 
high if above 7°C, CRT was considered prolonged if above 4.5 seconds.
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liver failure, and immunosuppression were associated with AKI in 
univariate analysis and were thus also included in the model. In the 
final multivariable analyses, increasing heart rate, subjectively cold 
extremities, and a prolonged CRT on the sternum were associated 
with AKI (AUROC entire model = 0.70, 98.5% CI 0.66‐0.74, H‐L GoF 
10.67, P = .22) (Table 3, E‐Figure 1).
3.1 | Sensitivity analyses
First, we evaluated the effect of adding lactate to the model. 
Adding lactate to the clinical examination findings‐based predic‐
tion model resulted in a small but statistically significant improve‐
ment in the prognostic performance (AUROC entire model = 0.72, 
95% CI 0.69‐0.75), P = .04 (E‐Table 3, E‐Figure 3). Since all vari‐
ables included reflect symptoms of circulatory shock, we also 
tested whether the presence of shock only defined by the need for 
vasopressors performed similar compared to the primary model, 
but the model including circulatory shock performed statistically 
significantly worse (AUROC 0.66 [95% CI 0.66‐0.73], P < .001, E‐
Table 4, E‐Figure 4).
4  | DISCUSSION
In this retrospective analysis of prospectively collected observa‐
tional data, we found that clinical examination findings are able 
to moderately predict the occurrence of AKI. Clinical examination 
could be used as initial trigger to raise awareness of the critically ill 
patients at risk for kidney failure and perform additional measures 
which help predict the occurrence of AKI.
Early detection and possible prevention of further kidney in‐
jury is of utmost importance to limit its consequences as still no 
treatment for AKI exists.21 Clinical examination consists of read‐
ily available signs, can be performed by anyone after training and 
could assist in early detection of AKI. While many studies included 
blood pressure and/or comorbidities in their analysis, only few 
addressed the association between a comprehensive clinical ex‐
amination and AKI. One study by Lima et al investigated the prog‐
nostic value of subjective peripheral perfusion assessment in 50 
critically ill patients and observed that patients with signs of ab‐
normal perfusion have a higher SOFA score. Renal function is an 
important component of the SOFA score, but this study did not ex‐
plore direct associations of clinical signs with AKI.22 Argyropoulos 
et al searched for risk factors which could assist in identifying 
those at risk for AKI upon ICU admission and created models that 
could quite accurately predict the occurrence of AKI.23 This study 
however only used laboratory data (such as urea and albumin) and 
defined AKI based on creatinine criteria only.23 Studying patients 
with septic AKI, Lara et al found that abnormal CRT in 95 septic 
patients with hyperlactatemia was associated with the need for 
RRT.24 Bourcier et al evaluated temperature gradients as proxy 
for tissue perfusion and found that it was associated with urine 
output in 40 critically ill patients with sepsis.25 Similarly, in our 
model subjectively cold temperature was associated with AKI. 
Measured temperature differences were however not associ‐
ated with AKI in multivariable analysis, which may be explained 
by the fact that subjective temperature is a more crude measure. 
Alternatively (subjective assessment of) temperature may be sus‐
ceptible to measurement error due to its inherent subjective na‐
ture. Poukkanen et al described how lower mean arterial pressure 
and lactate, amongst others, were associated with progression of 
AKI in patients with severe sepsis. 26 Although we only assessed 
one‐time clinical examination findings, and also included critically 
ill patients without sepsis, our results were in line with these stud‐
ies. The recent results of the ANDROMEDA trial suggest that in 
septic shock patients, targeting (signs of) peripheral perfusion 
during resuscitation might result in less organ failure, while no re‐
duction in 28‐day all‐cause mortality was observed.27
Recently, Bhatraju et al developed a three variable model to pre‐
dict severe AKI which performed excellent in a group of 1075 SIRS 
patients.3 This model yielded a much higher AUROC compared to 
our model, possibly explained by differences in AKI stage, and out‐
come definition. Moreover, the model was developed and validated 
internally in a highly selected population and includes a biomarker, 
which may not be available everywhere.3
F I G U R E  1   Flowchart of patient inclusion and types of AKI
TA B L E  3   Admission findings relevant for predicting AKI on day 
2 and 3 of ICU admission
 OR 98.5% CI P‐value
Age 1.02 1.00‐1.03 <0.001
Use of vasopressors 2.28 1.63‐3.20 <0.001
Liver cirrhosis 3.15 1.42‐7.00 <0.001
Heart rate, per 10 BMP 
increase
1.12 1.04‐1.22 <0.001
Subjectively cold 
temperature
1.52 1.07‐2.16 0.003
Prolonged 
CRT‐sternum
1.89 1.01‐3.55 0.013
*Description: model included 997 patients. Pseudo‐R2 = 0.09. Hosmer–
Lemeshow goodness‐of‐fit test χ2 11.58; P = .17. AUROC = 0.70 (98.5% 
CI 0.66‐0.74). Abbreviations: BPM, beats per minute, CRT, capillary 
refill time. CRT was considered prolonged if above 4.5 seconds. 
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Sensitivity analysis showed a small but significant improvement 
of the model by including lactate, which is not surprising given 
that lactate is a well‐recognized predictor of severity of illness and 
AKI.28,29 We did not include lactate in the primary model since it is 
likely not widely available as point of care test.18 Second, assessing 
circulatory shock as a single predictor was inferior to incorporating 
clinical examination signs and symptoms as separate predictors. 
Shock was herein defined as the need for vasopressors, which was a 
factor also included in the main model. Definitions of shock remain 
arbitrary, but we suggest that these results suggest that clinical signs 
individually predict AKI better compared to just the need for vaso‐
pressors. In a previous SICS‐I analysis, vasopressors were not asso‐
ciated with AKI, however, in that analysis a different subpopulation 
was included.30
Most of the included clinical signs reflect the underlying patho‐
physiology of shock, for example peripheral vasoconstriction. In 
patients who have just been admitted and are at an early stage of 
illness, tachycardia and peripheral vasoconstriction may still be pres‐
ent to maintain sufficient mean arterial pressure and/or for sufficient 
perfusion of vital organs. Peripheral vasoconstriction results in cold 
extremities, which was one of the factors predicting AKI in our pop‐
ulation. As mentioned, signs and symptoms depend on timing of the 
clinical examination. Even though there was a delay between ICU ad‐
mission and our clinical examination, patients present to ICU at a vari‐
able moment in their course of illness, which is not necessarily related 
to ICU admission time. If a patient is examined early during a septic 
event, the patient can be warm. In a later stage, patients are treated 
with vasopressors and extremities may become cold. From our re‐
sults, it seems as if those patients with poor clinical signs, had proba‐
bly not yet been fully resuscitated at the time of clinical examination.
4.1 | Implications and generalizability
Although clinical examination is operator dependent, the simplicity of 
the measures performed, and the detailed protocol provide accessible 
methods for other studies and reliable results. Our results provide in‐
formation on the value of clinical examination as a free, first‐line, and 
non‐invasive reasonable predictor for AKI, applicable in all settings 
when conducted properly. These observations may inform other stud‐
ies to include clinical examination when investigating additional vari‐
ables for the prediction of AKI. This study had a single centre design; 
collaboration with other centers and external validation should be per‐
formed to assess generalizability. We included a heterogenous popula‐
tion of critically ill patients, while investigation of the predictive value 
of clinical examination in subgroups might yield more specific clues.
4.2 | Limitations
Several limitations must be acknowledged. First, our study was a 
retrospective analysis of a prospective observational study, which 
hampers causal inferences by the current analysis. Second, we 
used the MDRD formula to estimate baseline serum creatinine 
(ie before illness) since these data were not collected in the main 
study. Even though this method is widely accepted, this might 
have led to either an over‐ or underestimation of AKI incidence.31 
Third, there are more signs of clinical examination that have been 
suggested to aid in identifying patients at risk of AKI, such as pe‐
ripheral edema, which we did not evaluate. Including other clinical 
variables in future studies might improve the predictive perfor‐
mances of clinical examination.32 Fourth, the highly dynamic na‐
ture of the pathophysiologic response to resuscitation and its 
translation into clinical signs, is probably not fully captured with 
a single clinical examination, which is why we currently include 
repeated measures in our follow‐up study, the SICS‐II.33 Last, to 
compare how these readily available variables perform best vs 
more advanced variables, we should have included some advanced 
measures such as imaging or biomarkers to compare model perfor‐
mance within a similar cohort.
5  | CONCLUSIONS
Clinical examination findings were able to predict AKI in critically 
ill patients, albeit with moderate accuracy. Clinical examination 
may be useful as a fast, free and non‐invasive first‐line assess‐
ment, ‘triggering’ additional measures that help predict the occur‐
rence of AKI.
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